These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16260083)

  • 1. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.
    Zhang XA; Lane WS; Charrin S; Rubinstein E; Liu L
    Cancer Res; 2003 May; 63(10):2665-74. PubMed ID: 12750295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
    Sridhar SC; Miranti CK
    Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of KITENIN, a KAI1/CD82 binding protein and metastasis enhancer, in bladder cancer cell lines: relationship to KAI1/CD82 levels and invasive behaviour.
    Rowe A; Jackson P
    Oncol Rep; 2006 Dec; 16(6):1267-72. PubMed ID: 17089048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
    Prabhu VV; Devaraj SN
    J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
    Wu Q; Ji Y; Zhang MQ; Chen YQ; Chen F; Shi DL; Zheng ZH; Huang YJ; Su WJ
    Cell Tissue Res; 2003 Nov; 314(2):237-49. PubMed ID: 12955496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
    Guo C; Liu QG; Zhang L; Song T; Yang X
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
    Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y
    Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KAI1 COOH-terminal interacting tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor, and enhances metastasis of cancer.
    Lee JH; Park SR; Chay KO; Seo YW; Kook H; Ahn KY; Kim YJ; Kim KK
    Cancer Res; 2004 Jun; 64(12):4235-43. PubMed ID: 15205336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor KAI1 affects integrin alphavbeta3-mediated ovarian cancer cell adhesion, motility, and proliferation.
    Ruseva Z; Geiger PX; Hutzler P; Kotzsch M; Luber B; Schmitt M; Gross E; Reuning U
    Exp Cell Res; 2009 Jun; 315(10):1759-71. PubMed ID: 19371633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
    Choi UJ; Jee BK; Lim Y; Lee KH
    Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1 tetraspanin and metastasis suppressor.
    Jackson P; Marreiros A; Russell PJ
    Int J Biochem Cell Biol; 2005 Mar; 37(3):530-4. PubMed ID: 15618009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
    Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
    Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration.
    Zhang XA; He B; Zhou B; Liu L
    J Biol Chem; 2003 Jul; 278(29):27319-28. PubMed ID: 12738793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
    Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
    Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
    Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
    Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.